The document is a bioRxiv preprint titled “Proteomics of human cancer-associated T cells identifies regulators of T cell functionality.” The preprint has the DOI https://doi.org/10.64898/2026.08.18.745433. As posted on bioRxiv, this work is explicitly identified as a preprint that has not been certified by peer review.
The manuscript lists multiple contributing authors. Lead and contributing investigators include Kaspar Bresser, Zan Hozjan, Nila H Servaas, Suzan Stelloo, Cornelia G Spruijt, Maia Nestor Martin, Aurelie Guislain, Nandhini Kanagasabesan, Stijn Kneefel, Arie Johan Hoogendijk, Carmen van der Zwaan, Ziva Moravec, Rhianne Voogd, Marja Nieuwland, Jessica Sieljes, Robert van Es, Kim Monkhorst, Koen Hartemink, Willemijn SME Theelen, Wouter Scheper, Michiel Vermeulen, and Monika C Wolkers.
Affiliations reported in the source text are predominantly Dutch research and clinical centres, including the Sanquin Blood Supply Foundation (Department of Research and Mass Spectrometry Laboratory), Amsterdam UMC Landsteiner Laboratory, Amsterdam Institute for Infection & Immunity, Cancer Center Amsterdam (Cancer Immunology), Radboud University and Radboud University Medical Center (Department of Urology; Department of Molecular Biology), Netherlands Cancer Institute (Division of Molecular Oncology & Immunology; Genomic Core Facility; Departments of Pathology and Surgery), University Medical Center Utrecht (Departments of Molecular Cancer Research and Stem Cells, Regenerative Medicine Center), and other associated core facilities and laboratories.
The title indicates that the authors applied proteomics to human cancer-associated T cells with the objective of identifying regulators of T cell functionality. From the title alone, the scope appears to include proteome-level characterization of T cells derived from a cancer context and a search for proteins or pathways that influence T cell behavior.
The supplied excerpt consists of the article header, author names, affiliations, DOI, and the bioRxiv preprint notice. It does not include the abstract, introduction, methods, results, figures, tables, discussion, or conclusions. The only verifiable elements in the supplied text are:
No experimental details, quantitative results, lists of identified proteins, functional validation experiments, statistical analyses, or specific candidate regulators are present in the excerpt provided.
The provided source text does not contain core study content necessary to evaluate the research findings. Specifically missing from the excerpt are:
Because these items are absent from the supplied text, no detailed interpretation of findings, claims of clinical significance, or protocol reproducibility can be made from this excerpt alone. Any statements about specific regulators, mechanisms, or validated outcomes would require consulting the full preprint.
To review the complete methods, data, and authors’ interpretations, readers should access the full preprint via the DOI link: https://doi.org/10.64898/2026.08.18.745433 or the bioRxiv page for this manuscript. When assessing findings reported in a preprint, consider that the work has not undergone peer review; verify details such as sample size, controls, data availability, and validation experiments in the full text. For clinical or translational application, prioritize results subsequently confirmed in peer-reviewed publications or independent replication studies.
Note: This rewritten summary and the headings above are drawn solely from the metadata and author/affiliation information present in the supplied bioRxiv excerpt. Study methods, results, identified proteins, and specific regulatory mechanisms were not reported in the provided text and therefore are not described here.